Oricula Therapeutics

0 followers

‌

Oricula Therapeutics is working to develop the first medication to be approved to prevent drug-induced hearing loss.

Industries

Pharmaceutical

Headquarters

Seattle, United States

Employees

1-10

Links

Org chart

Vince Groppi

Chief Executive Officer

Vince Groppi

Collapse

Graham Johnson

NuPharmAdvise, President

Marc Bailie

Chief Development Officer, INDS

David W. Raible

University of Washington, Professor

Henry Ou

University of Washington, Assoc Professor

Edwin W. Rubel

University of Washington, Chaired Professor

Teams

Leadership Team

5 members

Similar companies

Bristol-Myers Squibb

188 followers

Viatris

34 followers

Astellas Pharma

31 followers

Omnicell

20 followers

Syneos Health

18 followers

Catalent

17 followers

Organon

16 followers

NYU Langone Health

14 followers

Apellis Pharmaceuticals

8 followers

Parexel

7 followers

West Pharmaceutical Services

6 followers

Explore companies